ANB030-204: Ulcerative Colitis

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Ulcerative Colitis

Register Today!

Trial Information

Start DateOctober 2024
End DateN/A
Number of Visits~17 visits
StatusIn Start Up

For additional information
on this trial contact:

Phone(705) 566-0005